HEPLISAV-B achieved preliminary net product revenue of $268M for the full year 2024, an increase of 26% compared to $213M for the full year 2023. FY24 revenue consensus $276.94M
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.